
Linnea Lofdahl contributed to the Clinical-Genomics/cg repository by building and refining backend features that improved data integrity, workflow automation, and reliability in genomics order processing. She implemented robust API endpoints and automated tagging, enforced database constraints, and delivered idempotent migrations to support analytics and reporting. Using Python, SQLAlchemy, and CI/CD pipelines, Linnea focused on test-driven development, introducing integration and unit tests to ensure maintainability and early bug detection. Her work included refactoring workflow orchestration, enhancing error handling, and streamlining sequencing data management, resulting in more resilient pipelines and safer production operations across complex clinical genomics environments.

February 2026 (2026-02): Focused on data integrity improvements for PacBio sequencing data in the Clinical-Genomics/cg repository. Implemented non-null constraints on pacbio_sequencing_run.run_name, run_id, and unique_id to prevent missing identifiers and ensure reliable downstream analytics and reporting. Change delivered via a targeted schema modification in a single commit (PR #4866; hash f237f643b45cf85ecc2b035fd6d46afc85d71188).
February 2026 (2026-02): Focused on data integrity improvements for PacBio sequencing data in the Clinical-Genomics/cg repository. Implemented non-null constraints on pacbio_sequencing_run.run_name, run_id, and unique_id to prevent missing identifiers and ensure reliable downstream analytics and reporting. Change delivered via a targeted schema modification in a single commit (PR #4866; hash f237f643b45cf85ecc2b035fd6d46afc85d71188).
January 2026 performance summary for Clinical-Genomics/cg: Delivered core PacBio sequencing runs API with pagination and structured response models; added HiFi yield visibility in admin UI and sample endpoint; hardened sequencing QC to continue across all cases when a single check fails; improved repository hygiene by normalizing line endings and removing a dangerous init command to prevent production data resets. These changes enhance data accessibility, reliability, and production safety, driving better sequencing operations and governance.
January 2026 performance summary for Clinical-Genomics/cg: Delivered core PacBio sequencing runs API with pagination and structured response models; added HiFi yield visibility in admin UI and sample endpoint; hardened sequencing QC to continue across all cases when a single check fails; improved repository hygiene by normalizing line endings and removing a dangerous init command to prevent production data resets. These changes enhance data accessibility, reliability, and production safety, driving better sequencing operations and governance.
December 2025 monthly summary for Clinical-Genomics/cg focusing on reliability improvements in test infrastructure and streamlined pipeline tracking to enhance CI feedback and pipeline reproducibility.
December 2025 monthly summary for Clinical-Genomics/cg focusing on reliability improvements in test infrastructure and streamlined pipeline tracking to enhance CI feedback and pipeline reproducibility.
Clinical-Genomics/cg — 2025-11 monthly summary: Delivered targeted test automation improvements for critical startup work and a major bug fix to the delivery messaging path. Key contributions include Nallo start-available integration tests and dev-start-available test coverage with parameterized tests and sample creation utilities, plus refined test structure and config-file creation verification. A separate refactor made delivery message generation independent of app tags, enabling Microsalt workflows and fixing related errors by always using the delivery message path. These changes increase test coverage, reliability, and maintainability, and support Microsalt use cases for production workflows. Commits referenced: 26e76e94b19d7917458560d72064a4223285d381; 177e4fb830db9018bf45d72bafcab8b5fa55d2a6; 5d316d503f21deb57bd03a3e9a02e8a837c6f0d5.
Clinical-Genomics/cg — 2025-11 monthly summary: Delivered targeted test automation improvements for critical startup work and a major bug fix to the delivery messaging path. Key contributions include Nallo start-available integration tests and dev-start-available test coverage with parameterized tests and sample creation utilities, plus refined test structure and config-file creation verification. A separate refactor made delivery message generation independent of app tags, enabling Microsalt workflows and fixing related errors by always using the delivery message path. These changes increase test coverage, reliability, and maintainability, and support Microsalt use cases for production workflows. Commits referenced: 26e76e94b19d7917458560d72064a4223285d381; 177e4fb830db9018bf45d72bafcab8b5fa55d2a6; 5d316d503f21deb57bd03a3e9a02e8a837c6f0d5.
October 2025 performance summary for Clinical-Genomics/cg: Major refactor of the MIP-DNA workflow to use AnalysisStarter, with developer-focused commands to streamline configuration, startup, and execution. Reliability was enhanced through typing-friendly mocks, expanded unit tests for FastqFetcher, and new integration tests for the Balsamic workflow, improving readiness and initiation coverage. These changes deliver faster deployment of MIP-DNA cases with higher stability and reduced manual steps, strengthening production readiness and developer efficiency.
October 2025 performance summary for Clinical-Genomics/cg: Major refactor of the MIP-DNA workflow to use AnalysisStarter, with developer-focused commands to streamline configuration, startup, and execution. Reliability was enhanced through typing-friendly mocks, expanded unit tests for FastqFetcher, and new integration tests for the Balsamic workflow, improving readiness and initiation coverage. These changes deliver faster deployment of MIP-DNA cases with higher stability and reduced manual steps, strengthening production readiness and developer efficiency.
Month: 2025-09 — Clinical-Genomics/cg delivered improvements to start-available automation with stronger reliability and observability. Implemented end-to-end integration tests using pytest-httpserver, gated test execution to explicit requests to reduce CI noise, and enhanced logging to report the number of cases to be started across Balsamic, MIP, and Nextflow pipelines. Updated CI to include these tests, enabling earlier regression detection and better auditability. No major bugs fixed this month in cg. Overall impact: increased automation confidence, clearer pipeline workload visibility, and stronger cross-pipeline coordination.
Month: 2025-09 — Clinical-Genomics/cg delivered improvements to start-available automation with stronger reliability and observability. Implemented end-to-end integration tests using pytest-httpserver, gated test execution to explicit requests to reduce CI noise, and enhanced logging to report the number of cases to be started across Balsamic, MIP, and Nextflow pipelines. Updated CI to include these tests, enabling earlier regression detection and better auditability. No major bugs fixed this month in cg. Overall impact: increased automation confidence, clearer pipeline workload visibility, and stronger cross-pipeline coordination.
August 2025 (2025-08) monthly summary for Clinical-Genomics/cg: Delivered a targeted refactor of start command generation for Microsalt workflows. The start command construction was moved from the Submitter class to the MicrosaltCaseConfig model, introducing a new get_start_command method. This change removes the WORKFLOW_LAUNCH_COMMAND_MAP, reducing runtime decision points and simplifying future maintenance. The effort included comprehensive unit tests validating the new method and behavior, increasing startup reliability and test coverage. The change is tracked under commit 64a4260542553e54223d267367fdc4e1b9aa8d5c (Rework subprocess submitter (#4549)(patch)).
August 2025 (2025-08) monthly summary for Clinical-Genomics/cg: Delivered a targeted refactor of start command generation for Microsalt workflows. The start command construction was moved from the Submitter class to the MicrosaltCaseConfig model, introducing a new get_start_command method. This change removes the WORKFLOW_LAUNCH_COMMAND_MAP, reducing runtime decision points and simplifying future maintenance. The effort included comprehensive unit tests validating the new method and behavior, increasing startup reliability and test coverage. The change is tracked under commit 64a4260542553e54223d267367fdc4e1b9aa8d5c (Rework subprocess submitter (#4549)(patch)).
June 2025 – Clinical-Genomics/cg: Delivered a reliability enhancement for the Ticket Inbox Rsync workflow. Added a dedicated inbox-creation job executed before rsync to prevent race conditions, and refactored Slurm sbatch header generation to support optional headers and enforce dependency on successful inbox creation. This improves end-to-end ticket processing reliability, reduces intermittent rsync failures, and strengthens batch job orchestration. The change reduces manual troubleshooting and accelerates ticket ingestion and data movement, aligning with business goals for robustness and efficiency.
June 2025 – Clinical-Genomics/cg: Delivered a reliability enhancement for the Ticket Inbox Rsync workflow. Added a dedicated inbox-creation job executed before rsync to prevent race conditions, and refactored Slurm sbatch header generation to support optional headers and enforce dependency on successful inbox creation. This improves end-to-end ticket processing reliability, reduces intermittent rsync failures, and strengthens batch job orchestration. The change reduces manual troubleshooting and accelerates ticket ingestion and data movement, aligning with business goals for robustness and efficiency.
Concise monthly summary for 2025-05 focusing on Clinical-Genomics/cg: Key features delivered: - Implemented RAREDISEASE Order Type Migration: added a database migration to populate order_type_application with RAREDISEASE entries derived from MIP_DNA, with idempotent behavior to avoid duplicates when re-applying. Commits impacted: 71fcafc65bac6f1eb00d028342d798a35c0d1338 and e2f436ea2c8e4f043ec997424bb4d3460cc2ff2f. Major bugs fixed: - No major bugs fixed this month. The migration design emphasizes safety and idempotency to prevent state drift across environments. Overall impact and accomplishments: - Strengthened data integrity and reliability for rare-disease order processing. - Enabled consistent reporting and downstream analytics by ensuring accurate order_type_application population. - Reduced manual intervention and rework through an idempotent migration that safely re-runs if needed. Technologies/skills demonstrated: - Alembic migrations and idempotence patterns, Python/SQL data migrations, patch-level release discipline, data seeding for domain-specific entities.
Concise monthly summary for 2025-05 focusing on Clinical-Genomics/cg: Key features delivered: - Implemented RAREDISEASE Order Type Migration: added a database migration to populate order_type_application with RAREDISEASE entries derived from MIP_DNA, with idempotent behavior to avoid duplicates when re-applying. Commits impacted: 71fcafc65bac6f1eb00d028342d798a35c0d1338 and e2f436ea2c8e4f043ec997424bb4d3460cc2ff2f. Major bugs fixed: - No major bugs fixed this month. The migration design emphasizes safety and idempotency to prevent state drift across environments. Overall impact and accomplishments: - Strengthened data integrity and reliability for rare-disease order processing. - Enabled consistent reporting and downstream analytics by ensuring accurate order_type_application population. - Reduced manual intervention and rework through an idempotent migration that safely re-runs if needed. Technologies/skills demonstrated: - Alembic migrations and idempotence patterns, Python/SQL data migrations, patch-level release discipline, data seeding for domain-specific entities.
April 2025: Delivered automated external-data tagging for orders in Clinical-Genomics/cg. The feature scans each sample within an order and automatically appends the 'external-data' tag if any sample is external, improving data quality, categorization, and downstream workflow management. No major bugs fixed this month; focused on delivering a reliable tagging automation to enhance order processing and reporting. This release demonstrates careful scope control and traceability, with a compact change set and a clear commit history.
April 2025: Delivered automated external-data tagging for orders in Clinical-Genomics/cg. The feature scans each sample within an order and automatically appends the 'external-data' tag if any sample is external, improving data quality, categorization, and downstream workflow management. No major bugs fixed this month; focused on delivering a reliable tagging automation to enhance order processing and reporting. This release demonstrates careful scope control and traceability, with a compact change set and a clear commit history.
Monthly Summary for 2025-03 focused on reinforcing data integrity in order processing within the Clinical-Genomics CG repository. Implemented targeted validation for the capture_kit field in the order workflow, introduced a dedicated error type for invalid capture kits, and enforced that capture kits must be one of the allowed options. This change minimizes downstream processing errors, improves data quality, and supports governance and reporting accuracy.
Monthly Summary for 2025-03 focused on reinforcing data integrity in order processing within the Clinical-Genomics CG repository. Implemented targeted validation for the capture_kit field in the order workflow, introduced a dedicated error type for invalid capture kits, and enforced that capture kits must be one of the allowed options. This change minimizes downstream processing errors, improves data quality, and supports governance and reporting accuracy.
Overview of all repositories you've contributed to across your timeline